255 related articles for article (PubMed ID: 1742503)
21. [Morphologic findings in liver tissue in chronic active hepatitis B after seroconversion from HBeAg to anti-HBe].
Chlumská A; Stránský J; Taimr P; Baumruk L; Nevaril M
Vnitr Lek; 1995 Jul; 41(7):445-8. PubMed ID: 7571477
[TBL] [Abstract][Full Text] [Related]
22. Chronic active hepatitis in Italy: a multicentric study on clinical and laboratory data of 1154 cases. A report from the study group for CAH of the Italian Association for the Study of the Liver.
Hepatogastroenterology; 1983 Aug; 30(4):126-30. PubMed ID: 6629302
[TBL] [Abstract][Full Text] [Related]
23. Clinical impact and efficacy of lamivudine therapy in de novo hepatitis B infection after liver transplantation.
Castells L; Vargas V; Rodríguez F; Allende H; Buti M; Sánchez-Avila JF; Jardí R; Margarit C; Pumarola T; Esteban R; Guardia J
Liver Transpl; 2002 Oct; 8(10):892-900. PubMed ID: 12360430
[TBL] [Abstract][Full Text] [Related]
24. Clinical and virological course of chronic hepatitis B virus infection with hepatitis C and D virus markers.
Liaw YF; Tsai SL; Sheen IS; Chao M; Yeh CT; Hsieh SY; Chu CM
Am J Gastroenterol; 1998 Mar; 93(3):354-9. PubMed ID: 9517639
[TBL] [Abstract][Full Text] [Related]
25. [Relation of hepatitis B virus markers in the serum and hepatic tissue in chronic carriers of HBsAg].
Ferraz ML; Lanzoni VP; Silva AE; Alberti VN; Pereira CA; Chiferi Júnior V; Guimarães RX
AMB Rev Assoc Med Bras; 1989; 35(2):63-6. PubMed ID: 2695985
[TBL] [Abstract][Full Text] [Related]
26. [Clinical significance of HBeAg and anti-HBe in HBsAg positive liver diseases].
Takahashi A; Sekiya C; Yazaki Y; Tominaga Y; Oohara K; Ono M; Sato H; Hasebe C; Namiki M
Hokkaido Igaku Zasshi; 1983 Jan; 58(1):30-42. PubMed ID: 6840666
[TBL] [Abstract][Full Text] [Related]
27. [Severe acute hepatitis as initial manifestation of chronic hepatitis B virus infection].
Titó L; Sánchez Tapias JM; Mas A; Costa J; Bruguera M; Rodés J
Med Clin (Barc); 1989 Dec; 93(18):702-4. PubMed ID: 2607823
[TBL] [Abstract][Full Text] [Related]
28. [Long-term prognosis of chronic B and C viral hepatitis].
Ohlen J; Liegl JM; Selmair H
Leber Magen Darm; 1995 Sep; 25(5):205-10. PubMed ID: 7500807
[TBL] [Abstract][Full Text] [Related]
29. [Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?].
Maier KP; Lepiorz H; Berthold H; Gerok W
Leber Magen Darm; 1982 Aug; 12(4):150-3. PubMed ID: 7132529
[TBL] [Abstract][Full Text] [Related]
30. [Value of puncture biopsy of the liver during diagnostic and follow-up examinations (clinical aspects, immunological markers, images) in chronic hepatitis].
Gonvers JJ
Schweiz Med Wochenschr; 1986 Aug; 116(31-32):1030-5. PubMed ID: 2428101
[TBL] [Abstract][Full Text] [Related]
31. Hepatitis B virus infection and hepatocellular carcinoma among parous Taiwanese women: nationwide cohort study.
Fwu CW; Chien YC; Kirk GD; Nelson KE; You SL; Kuo HS; Feinleib M; Chen CJ
J Natl Cancer Inst; 2009 Jul; 101(14):1019-27. PubMed ID: 19535774
[TBL] [Abstract][Full Text] [Related]
32. A three-month course of lamivudine therapy in HBeAg-positive hepatitis B patients with normal aminotransferase levels.
Yalçin K; Değertekin H; Kokoğlu OF; Ayaz C
Turk J Gastroenterol; 2004 Mar; 15(1):14-20. PubMed ID: 15264116
[TBL] [Abstract][Full Text] [Related]
33. Delta virus infection in Jerusalem.
Schuger L; Bonino F; Mushahwar IK; Ron N; Shouval D
Isr J Med Sci; 1988 Mar; 24(3):156-9. PubMed ID: 3286578
[TBL] [Abstract][Full Text] [Related]
34. [Relation between viral antigens in hepatic tissue detected by immunofluorescence and serological markers of HBV infection in patients with chronic hepatitis].
Calzia R; Ciravegna B; Navone C; Tolentino P
Boll Ist Sieroter Milan; 1982; 61(4):347-56. PubMed ID: 6765398
[TBL] [Abstract][Full Text] [Related]
35. A 28-year study of the course of hepatitis Delta infection: a risk factor for cirrhosis and hepatocellular carcinoma.
Romeo R; Del Ninno E; Rumi M; Russo A; Sangiovanni A; de Franchis R; Ronchi G; Colombo M
Gastroenterology; 2009 May; 136(5):1629-38. PubMed ID: 19208358
[TBL] [Abstract][Full Text] [Related]
36. Clinical and epidemiological significance of hepatitis delta virus (HDV) infection in chronic HBV carriers in Portugal.
Ramalho F; Carvalho G; Bonino F; Baptista A; de Moura MC
Prog Clin Biol Res; 1987; 234():409-17. PubMed ID: 3628400
[TBL] [Abstract][Full Text] [Related]
37. Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease.
Kumar M; Sharma BC; Sarin SK
J Gastroenterol Hepatol; 2008 Jun; 23(6):883-7. PubMed ID: 18070014
[TBL] [Abstract][Full Text] [Related]
38. Influence of HDV infection on clinical, biochemical and histological presentation of HBsAg positive chronic hepatitis.
Sagnelli E; Felaco FM; Filippini P; Pasquale G; Peinetti P; Buonagurio E; Aprea L; Pulella C; Piccinino F; Giusti G
Liver; 1989 Aug; 9(4):229-34. PubMed ID: 2770435
[TBL] [Abstract][Full Text] [Related]
39. [Retrospective study in hepatic biopsies, of hepatitis B surface antigen by the orcein method and indirect immunofluorescence methods].
Caldas ML; Maffei HV; Rezende TA; Takeda AK; Miranda AF; Franco MF
Arq Gastroenterol; 1979; 16(4):169-74. PubMed ID: 95161
[TBL] [Abstract][Full Text] [Related]
40. [Incidence of cryoglobulinemia in a series of cases of chronic liver diseases].
Ruggiero G; Spadacenta F; Gargiulo M; Miraglia E; Gianturco G
Minerva Med; 1979 Sep; 70(42):2863-7. PubMed ID: 492553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
